{
    "clinical_study": {
        "@rank": "1609", 
        "biospec_descr": {
            "textblock": "blood, urine"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the usefulness of plasma 1,5-anhydro-D-glucitol\n      (1,5-AG) as a novel surrogate marker of hypoglycemia"
        }, 
        "brief_title": "The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With Diabetes", 
        "condition": "Hypoglycemia, Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Hypoglycemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "We enrolled well controlled diabetes patients who had hypoglycemic event at least one time\n      more. All patients assess the risk of severe hypoglycemia and hypoglycemic unawareness using\n      hypoglycemic awareness questionnaires (HYPO score). The patients who are treated with\n      insulin agent were inserted sensor of continuous glucose monitoring systems under the skin\n      during three days. We were analysed the correlation between 1,5-anhydro-D-glucitol and HYPO\n      score."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients attending outpatients of department of endocrinology and metabolism, seoul\n             national university hospital .(HbA1C <8%)\n\n          -  The patients who treated with insulin or sulfonylureas at least 3month period\n\n          -  In case fo sulfonylurea user, HbA1c was restricted under 8%\n\n          -  The patients who had hypoglycemic event at least 3 months\n\n          -  who has can be survey questionnaire\n\n          -  who can insert continuous glucose  monitoring system\n\n        Exclusion Criteria:\n\n          -  renal dysfunction patients\n\n          -  hepatic dysfunction patients\n\n          -  who has any kind of diseases, operations, medical treatments that can affect glucose\n             levels"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "41", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02068300", 
            "org_study_id": "1,5AG_Hypo"
        }, 
        "intervention_browse": {
            "mesh_term": "Sorbitol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker", 
        "lastchanged_date": "May 14, 2014", 
        "location": {
            "contact": {
                "email": "moongio@daum.net", 
                "last_name": "Min Kyeong Kim, MD", 
                "phone": "82-2-2072-0982"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Hye Seung Jung, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "other_outcome": {
            "measure": "The plasma 1,5-anhydro-D-glucitol leve may be a useful marker of daily glucose excursion in diabetes patients", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "overall_contact": {
            "email": "jungjhs@gmail.com", 
            "last_name": "Hye Seung Jung, MD", 
            "phone": "+82-2-2072-0240"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Hye Seung Jung, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Modified hypoglycemic score was calculated by modified Clarke et al. questionnaire.", 
            "measure": "The correlation between 1,5-anhydro-D-glucitol and Modified Hypoglycemic score", 
            "safety_issue": "No", 
            "time_frame": "within the least 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02068300"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Hye Seung Jung", 
            "investigator_title": "associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Modified hypoglycemic score was calculated by modified Clarke et al. questionnaire.\nContinuous glucose monitoring system was performed to find hypoglycemic event and glycemic variability in insulin using patients.", 
                "measure": "The correlation between hypoglycemic percent of Continuous glucose monitoring system and modified hypoglycemic score in insulin using patients.", 
                "safety_issue": "No", 
                "time_frame": "within at leat 3months"
            }, 
            {
                "description": "Modified hypoglycemic score was calculated by modified Clarke et al. questionnaire.\nContinuous glucose monitoring system was performed to find hypoglycemic event and glycemic variability in insulin using patients.", 
                "measure": "The relation between MAGE (mean amplitude of glycemic excursion) of continuous glucose monitoring system and modified hypoglycemic score in insulin using patients.", 
                "safety_issue": "No", 
                "time_frame": "within at least 3months"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}